This site is intended for healthcare professionals
Optimising anti-TNF treatment using biosimilars Learning Zone

Expert Opinion

Last updated:11th Nov 2020
Published:29th Oct 2020
Explore independently led content from leading experts on the use of αTNF biosimilars to treat three conditions.

Do you know the latest insights on the use of αTNF biosimilars in rheumatoid arthritis, hidradenitis suppurativa and inflammatory bowel disease? Watch these expert-led videos on treatment initiation, optimisation, maintenance and treatment during COVID-19.

In these illuminating interviews, Professor Thomas Dörner, Dr Joana Cabete and Dr Nick Kennedy explore the role of αTNF biosimilars in these conditions.

Know the latest insights on the use of αTNF biosimilars in rheumatoid arthritis? Watch these videos on treatment initation and optimisation.

Biological disease-modifying antirheumatic drugs (DMARDs), such as anti tumour necrosis factor (αTNF), are an important component of treatment for patients with rheumatic diseases1.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Want to hear the latest on hidradenitis suppurativa? Watch the videos below to learn about the unmet needs of this disease, the use of αTNF treatment and the impact of COVID-19.

Hidradenitis suppurativa (HS) is a prevalent and devastating inflammatory skin disease characterised by painful recurrent abscesses, foul-smelling purulent drainage, sinus tract and fistula formation, and disfiguring scarring involving intertriginous body sites1.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Watch these videos to find out the latest advice on treating inflammatory bowel disease covering the initiation, optimisation and maintenance of treatment and impact of COVID-19.

Inflammatory bowel diseases can result in debilitating physical and psychosocial symptoms for patients and affect society through loss of schooling, absenteeism, and health-care costs1.

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Welcome: